Arvinas Inc
ARVN
$8.30+0.12%
End of day · as of Sep 21, 2026, 11:16 PM ET
Mkt cap
$478.75M
EV/Sales
1.28
P/E ratio
N/A
FY2025 Revenue
$262.60M
EPS (H1 2026)
$1.70
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-30.77%
Beta
1.75
Div yield
N/A
Sector
Healthcare
Arvinas Inc (ARVN) is a biotechnology company listed on US.
Latest reported ARVN revenue for 2025-12-31 was $262.6M. Net income was -$80.8M. Revenue was down 0.3% from 2024-12-31 to 2025-12-31. ARVN currently screens at market cap $478.7M.
Use this ARVN research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ARVN income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Arvinas Inc (ARVN) is a biotechnology company in the Healthcare sector.
Latest cached Arvinas Inc (ARVN) revenue for Dec 31, 2025 was $262.6M. Net income was -$80.8M. Statements: https://lician.com/financials/arvn
Arvinas Inc (ARVN) market capitalization is $478.7M on the latest cached snapshot.
Arvinas Inc (ARVN) cached previous close $8.29; day range $8.21 – $8.44; volume 639,834. Session quote: https://lician.com/quote/arvn
Arvinas Inc (ARVN) latest cached earnings event is "ARVN earnings" on Aug 5, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ARVN filing is 8-K · Aug 4, 2026. Filings: https://lician.com/sec/arvn